Friday, August 31, 2018 11:53:11 AM
----------------
YES, very interesting. We have products in Germany, don't we? Wonder how trading on a foreign exchange affects the price of stock here?
Anyway, anything is better than trading on this crap Pink Sheet Exchange.
Another association with Bayer? hmmmmmm.
I think we can start to assume that when the Dr. Scholl's deal is confirmed, that 'licensing deals' is what has been decided as the way to go. Then, if they (Bayer) are not taking the whole company, can we start speculating on other licensing partners for the other products present and future? IMO, 'licensing products' decision would be the best and if that becomes evident, it will fuel the stock price going forward.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM